- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06094569
Medical Imaging Screening for Posterior-circulation Ischemic Stroke
October 16, 2023 updated by: Ming Wei, Tianjin Huanhu Hospital
Medical Imaging Screening for Posterior-circulation Ischemic Stroke:a Multicentre,Imaging-based,Prospective Cohort Study
Patients with ischemic stroke in the posterior circulation continue to have high rates of mortality and disability, even with aggressive treatment.
We wanted to evaluate preoperative imaging to screen patients with a good prognosis from mechanical embolization.
We assess the degree of ischemia by defining the pons-midbrain-medulla index (PMMI) and correlate the preoperative PMMI with the clinical prognosis of postoperative patients to verify the validity of PMMI in predicting the clinical prognosis of patients with embolization.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
- The ENDOSTROKE registry (Endovascular Stroke T reatment Registry), the use of MRI before EVT was associated with significantly better clinical outcomes as compared to CT.
- The purpose of the study will sift patients with posterior circulation ischemia stroke who will get better outcome by Mechanical Thrombectomy by neuroimaging.Specifically, the following assumption will be evaluated: the modified pons-midbrain index in magnetic resonance imaging can predict the clinical outcome of patients with basilar artery thrombosis 90 days after surgery, and can guide whether patients will undergo mechanical thrombectomy later.
- Pons-midbrain-medulla index (PMMI) : We divide pons-midbrain-medulla into the left and right sides by the median line of the brainstem,so we will evaluate ischemia of these six layers which are endowed different score according to the degree of ischemia. Instead of the previous pons-midbrain index (PMI), we select the image layer that shows the largest infarct size among the six parts.Then,we add up six scores that is patient's PMMI. Scoring criteria: At the layer of displaying the maximum infarct size, 2 points are scored if the infarct size exceeds 50% of the total area, 1 point is scored if the infarct size is less than 50% of the total area, and 0 points are scored if there is no infarct.Finally, PMMI values range from 0 to 12 points.
- The investigators conduct a multicenter, prospective cohort study.Preoperative images of patients are evaluated by different groups of imaging physicians to describe the association between preoperative PMMI and clinical prognosis in patients with posterior circulation stroke and to verify its validity.
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ming Wei, PhD
- Phone Number: 13502182903
- Email: drweiming@163.com
Study Locations
-
-
Tianjin
-
Tianjin, Tianjin, China, 300052
- Recruiting
- Tianjin Medical University General Hospital
-
Contact:
- Xuanye Yue, MD
- Phone Number: 022-60814622
- Email: yuexy2002@aliyun.com
-
Principal Investigator:
- Xuanye Yue, MD
-
Tianjin, Tianjin, China, 300222
- Recruiting
- Tianjin Huanhu Hospital
-
Principal Investigator:
- Ming Wei, PhD
-
Contact:
- Ming Wei, PhD
- Phone Number: 13502182903
- Email: drweiming@163.com
-
Tianjin, Tianjin, China, 300211
- Recruiting
- The Sencond Hospital of Tianjin Medical University
-
Contact:
- Zhenjian Ma, MD
- Phone Number: 18322412226
- Email: mazhenjian@126.com
-
Principal Investigator:
- Zhenjian Ma, MD
-
Tianjin, Tianjin, China, 300450
- Recruiting
- Beijing University Binhai Hospital
-
Contact:
- Wanchao Shi, MD
- Phone Number: 15620177339
- Email: swc9801@sina.com
-
Principal Investigator:
- Wanchao Shi, MD
-
Contact:
- Phone Number: Wanchao
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
All acute ischemic strvoke patients with vertebrobasilar artery occlusion.
Description
Inclusion Criteria:
- Patient admitted from Jun. 1st 2019 to Jan. 1st 2029;
- Patients with acute ischemic stroke recently;
- Symptoms persisted at admission, and MRI (including DWI) confirmed acute ischemic vertebrobasilar artery occlusion in the posterior circulation:(single right or left intracranial branch of vertebral artery occlusion ; single basilar occlusion ; both two vertebral arterys and basilar artery);
Exclusion Criteria:
1.Patiens can not meet the MRI examination conditions(with absolute and relative contraindications).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Endovascular therapy
Timely thrombectomy for acute ischemic stroke patients with large vessel occlusion by either stent retriever, thrombus aspiration, others, or combination methods.
|
Endovascular therapy, as an adjunct to standard stroke therapy, may be beneficial for a very select population of patients who present with an acute ischemic stroke and have a proven large, proximal occlusion on imaging.
Endovascular therapy includes any one or more of the following: Intra-arterial thrombolytic therapy, aspiration, stent retrieval, or a combination of multiple mechanical devices
|
|
Best medical management
Patients enrolled in this group received the best medical management.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified ranking scale (mRS) at 90 days
Time Frame: 90 days
|
A 0-6 scale running from perfect health without symptoms to death.
|
90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mortality within 90 days
Time Frame: 90 days
|
mortality of any causes.
|
90 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
National Institutes of Health Stroke Scale (NIHSS) scores at 90 days
Time Frame: 90 days
|
The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment.
The individual scores from each item are summed in order to calculate a patient's total NIHSS score.
The maximum possible score is 42, with the minimum score being a 0.
|
90 days
|
|
Occurrence of periprocedural complications
Time Frame: 90 days
|
Periprocedural complications include any intracranial hemorrhage, cerebral edema, brain herniation and pneumonia.
|
90 days
|
|
pc-ASPECT (posterior circulation Alberta Stroke Program Early CT score)
Time Frame: 0 days
|
pc-ASPECTS is a 10-point quantitative topographic CT scan score used in patients with posterior circulation stroke.
|
0 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2019
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2029
Study Registration Dates
First Submitted
October 16, 2023
First Submitted That Met QC Criteria
October 16, 2023
First Posted (Actual)
October 23, 2023
Study Record Updates
Last Update Posted (Actual)
October 23, 2023
Last Update Submitted That Met QC Criteria
October 16, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TJHH-2023-wm14
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endovascular Thrombectomy
-
Hamilton Health Sciences CorporationCompletedBlood Pressure | Stroke, Acute | Mechanical Thrombectomy | Endovascular Thrombectomy | Vessels; OcclusionCanada
-
University of CincinnatiNational Institute of Neurological Disorders and Stroke (NINDS); Vanderbilt...CompletedAcute Stroke | Endovascular ThrombectomyUnited States
-
Hui-Sheng ChenCompletedStroke | Endovascular ThrombectomyChina
-
Tianjin Huanhu HospitalRecruitingEndovascular ThrombectomyChina
-
Sunnybrook Health Sciences CentreUnknownOptical Coherence Tomography | Stroke of Basilar Artery | Endovascular Thrombectomy | AntithromboticsCanada
-
Xiang LuoRecruitingAcute Ischemic Stroke | Arterial Occlusion | Minocycline | Endovascular Thrombectomy | Posterior CirculationChina
-
The First Affiliated Hospital of University of...RecruitingAcute Ischemic Stroke | Endovascular ThrombectomyChina
-
The First Affiliated Hospital of University of...RecruitingAcute Ischemic Stroke | Endovascular ThrombectomyChina
-
RenJi HospitalChanghai Hospital; Huashan Hospital; Second Affiliated Hospital, School of Medicine... and other collaboratorsRecruitingAcute Ischemic Stroke | Endovascular ThrombectomyChina
-
Xijing HospitalRecruitingIschemic Stroke, Acute | Endovascular ThrombectomyChina
Clinical Trials on Endovascular Therapy
-
Stanford UniversityEnrolling by invitationStroke, Acute | Ischemic Stroke, AcuteUnited States
-
Xuanwu Hospital, BeijingNot yet recruitingIschemic Stroke | Basilar Artery Occlusion | Large Core InfarctChina
-
RenJi HospitalRecruitingHemodialysis Access Failure | Arteriovenous Fistula | Angioplasty, BalloonChina
-
RenJi HospitalRecruitingHemodialysis Access FailureChina
-
Chinese Academy of Medical Sciences, Fuwai HospitalNot yet recruitingRenal Artery Obstruction | Hypertension, RenovascularChina
-
University Hospital, Basel, SwitzerlandStryker Neurovascular; Medtronic; Swiss National Fund for Scientific Research; Phenox... and other collaboratorsActive, not recruitingAcute Ischemic StrokeNetherlands, Sweden, Spain, Finland, Belgium, Switzerland, Germany, Israel, Italy, Portugal, United Kingdom
-
Xuanwu Hospital, BeijingFudan University; RenJi Hospital; Huashan Hospital; First Affiliated Hospital of... and other collaboratorsCompletedChronic Limb-threatening Ischemia | Endovascular TherapyChina
-
Hyogo Medical UniversityRecruitingAcute Ischemic Stroke | Endovascular Therapy | Acute Ischemic Stroke (AIS) Related to a Distal OcclusionJapan
-
RenJi HospitalRecruitingHemodialysis Access FailureChina